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Abstract 
Proper understanding of blood-brain barrier (BBB) regulation is crucial to reduce/prevent its disruption 
during injury. Since high brain complexity makes interpretation of in vivo data challenging BBB 
studies are frequently performed using simplified in vitro models. Although such models represent an 
important and frequently employed alternative for investigation of BBB function and alterations, our 
ability to translate in vitro findings to in vivo situation remains sub-optimal. Consequently, despite the 
fact that our knowledge of the cellular and molecular mechanisms underlying BBB physiology and 
pathophysiology is constantly increasing, our ability to modulate barrier function remains virtually 
non-existent. Classical in vitro model systems have provided a wealth of knowledge until now, but it is 
now evident that newer in vitro models that are more representative of the in vivo situation are needed 
to further our understanding of barrier physiology.  
This paper will provide an overview of the BBB cellular components and the most frequently used in 
vitro BBB model systems. I will discuss their advantages and disadvantages, as well as highlight 
recently developed models that more closely mimic the BBB in vivo. 
 
Introduction 
The blood-brain barrier (BBB) is a selective vascular barrier that maintains brain homeostasis. The 
BBB is dynamic and performs both passive and active features of the brain endothelium (1-3). It acts as 
a physical barrier due to presence of tight junction complexes between adjacent endothelial cells 
preventing the paracellular movement of molecular traffic across the BBB. By permitting or facilitating 
the entry of required nutrients while excluding or effluxing potentially harmful compounds via specific 
transport systems located on the endothelial luminal and abluminal membranes it also acts as a 
selective transport barrier. It is also a metabolic barrier due to the combination of intracellular and 
extracellular enzymes that inactivate many neuroactive and toxic compounds or metabolize peptides 
and ATP. All these tasks are critical since in their absence the homeostatic neuronal environment 
within the central nervous system would be significantly compromised leading to neuronal 
hyperactivation and malfunction (4, 5). It is therefore not surprising that alterations in BBB function 
have been associated with multiple pathologies and may represent a cause or consequence of disease 
progression with overall negative outcomes. On the other hand the ability of the BBB to efficiently 
exclude the entrance of foreign substances to the brain means that it also represents a formidable 
obstacle for drug entry and treatment of brain pathologies and other diseases (3, 4). Thus the 
conundrum for vascular biologists at present is how to maintain the barrier during injury but also 
facilitate selective opening to enable drug access. 
In vivo, the BBB is a structure that is not easily accessible for study. The BBB exists as a complex 
microvascular network throughout the brain and therefore is difficult to isolate and target specific 
mechanisms. In addition, the complex cellular interactions within the brain parenchyma make it 
problematic to identify the specific contribution of the various cellular components and pathways to 
barrier function. Various animal injury models are used to study different diseases characterized by loss 
of BBB integrity but despite this fact, the induction and maintenance of the BBB is still poorly 
understood (3). Thus many researchers have developed in vitro model systems that represent highly 
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simplified models of the BBB to foster a more in depth understanding of the mechanisms and signaling 
pathways involved in barrier function. In vitro models are powerful cell-based assays and versatile 
experimental tools that can be used to study different features of the barrier in normal and pathological 
states. This review will compare various aspects of 2 and 3 dimensional models, their pros and cons 
and overall contribution to our knowledge of barrier induction and maintenance.  
 
Cellular components of the BBB 
The BBB is a sophisticated multicellular structure that is maintained by complex interactions between 
capillary endothelial cells, the basement lamina, pericytes and astrocytic endfeet processes (reviewed 
by (6)), which together with neurons and microglia form an organization referred to as the 
neurovascular unit (NVU).  
The basement membrane is an essential part of the BBB that surrounds the capillaries thereby 
anchoring the cells in place and providing the link with the resident brain cells. Astrocytes, pericytes 
and endothelial cells themselves all contribute to the basement membrane that consists of structural 
proteins, collagens and specialised proteins (7). Disruption of the basement membrane can affect tight 
junction protein expression in the endothelium and has been associated with increased BBB 
permeability in various pathological conditions (8-10).  
The endothelia of cerebral capillaries form the anatomic basis of the BBB in higher organisms (1, 11). 
Unlike the endothelium of other vascular beds, specialized cerebral microvessel endothelial cells have 
very low permeability due to the presence of highly organized junctional complexes called tight 
junctions (TJs). TJs ensure stringent regulation of CNS homeostasis by severe restriction of the 
paracellular diffusional pathway between the endothelial cells and substances and/or cells within the 
circulating blood (12). TJs are elaborate structures that span the apical region of the intercellular cleft 
of epithelial and endothelial barrier tissues functioning both as a "zipper" that effectively separates the 
apical and basolateral cell membranes enabling asymmetric distribution of membrane constituents, and 
a "fence" that limits paracellular permeability (12, 13). TJs respond quickly to intracellular signaling 
events and thus are highly dynamic structures that rapidly change expression, subcellular localization, 
and post-translational modifications, which in turn affect protein–protein interactions (13, 14). The 
effectiveness of endothelial TJs appears to be regulated via the intracellular scaffold proteins of the 
zonal occludens family that link the junctional molecules claudin and occludin to the cytoskeleton (7, 
11, 15). Current evidence suggests that the claudins constitute the backbone of TJ strands and occludin 
plays a more permeability-regulating role by incorporating itself into the claudin-based strands 
(reviewed by (16)). The mechanism by which this occurs, and indeed the precise role(s) of occludin 
remain to be elucidated. An additional contribution of adherens junctions to stabilization of endothelial 
cell–cell interactions at the junctional zone has been recently reviewed (17, 18).  
Notably, capillary endothelial cells do not intrinsically form a BBB but are induced by the CNS 
environment. Signalling among the BBB cells is thought to occur via soluble and solid phase factors 
and their cognate receptors. In this respect the participation of astrocytes has been most widely studied. 
Astrocytes are thought to induce the barrier phenotype of cerebrovascular endothelial cells during 
development through release of soluble factors such as vascular endothelial growth factor (VEGF), 
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TGF , IL-6 and nitric oxide (19-23). In general astrocytes are now accepted to play a decisive role not 
only in maintaining barrier properties of brain microcapillary endothelial cells (2, 24, 25), but also in 
direct control of cerebral blood flow (26, 27) and regulation of water homeostasis (28, 29). 
In contrast, the contribution of pericytes to BBB phenotype has until recently remained more obscure 
(4). Pericytes were suggested to be involved in capillary contraction due to their expression of 
contractile proteins and intimate contact with endothelial cells (30), and in the retinal vasculature were 
shown to be important for retinal barrier function (31). Subsequent in vitro studies also suggested that 
pericytes enhance BBB function (32, 33). Very recently additional evidence was provided by some 
elegant in vivo studies. Platelet-derived growth factor (PDGF)-B, a high affinity ligand for the receptor 
tyrosine kinase PDGF-R  expressed on peric         
and is critical for vascularization of the brain. Indeed disruption of the PDGF-B gene led to pericyte 
loss, endothelial hyperplasia, and prenatal lethality (34, 35). Using viable pericyte-deficient adult 
mouse models it has now been demonstrated that pericytes are necessary for the formation of the BBB 
as well as regulate functional aspects, including the formation of tight junctions and vesicle trafficking 
in CNS endothelial cells, astrocyte polarization and integration of cellular functions at the NVU (36, 
37). Another group also showed that age-dependent vascular damage in pericyte-deficient mice 
precedes neuronal degenerative changes, learning and memory impairment, and the neuroinflammatory 
response (38). Thus, pericytes control key neurovascular functions that are necessary for both BBB 
maintenance and proper neuronal structure and function. 
 
Targeting the BBB to fight disease 
As stated above, cellular interactions and local release of factors, in addition to signals from circulating 
substances, have marked effects on TJ expression and barrier integrity. Thus it is not surprising that 
barrier disruption has been associated with a number of CNS pathologies including Parkinson's and 
Alzheimer's disease (5, 8), multiple sclerosis (39), hypoxia and ischemia (40), edema (41), 
tumorigenesis (42), epilepsy (43, 44) and glaucoma (45). The degree of dysfunction can range from 
mild and transient tight junction opening to chronic barrier breakdown. It is frequently unclear whether 
disease onset per se is triggered by barrier compromise, but its disturbance can contribute to, and 
exacerbate, the developing pathology (46).  
The role of astrocytes and pericytes in BBB maintenance during brain injury or pathological 
progression has not been well addressed. Current research advocates that astrocytes support endothelial 
cell survival during hypoxia/ischemia and maintain barrier function (40, 47-49). Pericytes also seem to 
reduce paracellular flux across the barrier (32, 50). Reports of secretion of TGF-β (51, 52), 
erythropoietin (53), glial derived neurotrophic factor and neurotrophin (54) by astrocytes and/or 
pericytes during cerebral hypoxia/ischemia reveals the diversity of injury-regulated factors that might 
promote barrier maintenance and cell survival in endothelial cells during injury. However our own 
recent studies suggest that the ability of either cell type to maintain barrier function is profoundly and 
differentially modulated by severity and duration of the insult (50). For example during acute hypoxic 
insult astrocytes protected the endothelial barrier better than pericytes whereas during prolonged 
hypoxic insult pericytes were more protective than astrocytes, a discrepancy that may be attributable to 
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differences in modulation of specific signalling pathways and subsequent released factors such as 
VEGF (50). Undoubtedly direct but differential effects of injury processes on either astrocytes or 
pericytes must have significant consequences for BBB function and disease progression. Hence barrier 
maintenance is a complicated and highly regulated process involving multiple pathways. Until now the 
highly coordinated signalling mechanisms that exist between the specific cellular components of the 
BBB during injury remain obscure.  
As early intervention offers the best possibility of reducing long-term disease progression and disability 
(3), the current challenge for the field is to develop better diagnostic methods to identify barrier 
disturbance and ways to therapeutically target the BBB to prevent barrier compromise. However it 
should not be forgotten that the opposite approach - selectively opening the tight junctions of the 
endothelium to facilitate drug delivery to the brain - is also an area of intense research. To achieve 
these aims we need to have a much better understanding of BBB function and regulation. Notably, 
since the contribution of individual cell types is crucial, identification and targeting of cell-specific 
mechanisms may gain better results than have been currently obtained using more global approaches. 
In vitro model systems have a significant role to play in this respect. 
 
In vitro model systems 
In vitro modeling has greatly contributed to the BBB field. These simplified systems allow 
investigation and more accurate interpretation of experiments that are impossible, or at best highly 
complicated, to perform in vivo. Such models have increased our understanding of how influx and 
efflux of endogenous substances are controlled. Furthermore they have provided insight into the 
contribution of individual cell types to specific functions of barrier regulation, physiological as well as 
pathological processes. The fact that they are versatile, relatively easy to implement and inexpensive 
compared to in vivo models also makes them a frequently employed resource. 
However in vitro model systems are unable to fully recreate all aspects of the in vivo situation and are 
limited predominantly by the type of brain endothelial cells used. Immortalized cell lines are more 
frequently utilized (due to the difficult isolation procedures of primary cells, reduced yield and cell 
contamination by other cell types) but are often less representative of the in vivo characteristics due to 
loss of significant barrier function during passage (55, 56). A comprehensive list of endothelial cell 
lines frequently employed in BBB model systems has been reviewed (57, 58). Importantly, data 
obtained from in vitro models must take into account any differences in species of the cell types used 
and consider that correlations between in vitro and in vivo results may diverge. Despite these caveats in 
vitro systems still represent an important resource to improve our understanding of barrier function. 
Current in vitro model systems can be broadly placed into two categories namely 2 and 3 dimensional 
(2D and 3D respectively) models. Both have advantages and disadvantages that should of course be 
taken into consideration before beginning relevant studies. The strength of the 2D model lies in the 
ability to directly assess barrier function within an endothelial monolayer. In contrast 3D models foster 
cellular movement and organization of dynamic cell-cell interactions that are more analogous to those 
that occur in vivo.  
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2D models 
Two-dimensional cell culture models form the majority of BBB in vitro models currently in use and are 
based on systems developed in the 80’s and 90’s (24, 56, 59). These models evaluate various aspects of 
pharmacology, transport, migration and metabolic activity of the BBB. The experimental set up 
consists of endothelial cells cultured on one side of a cell-culture insert with porous filter membrane 
(transwell system), allowing formation of a monolayer and induction of cell polarity (see Fig. 1). The 
functional barrier phenotype is quantified by means of 1) classic transendothelial electrical resistance 
(TEER) measurements that assess the resistance of the monolayers exposed to electrical current (60) or 
2) permeability assays that assess the diffusion/extravasation of labeled proteins and/or cells through 
the monolayer (60). However, very early models based on endothelial monocultures quickly revealed a 
limitation of significantly reduced TEER values (10-100Ω) compared to the in vivo situation (>1000Ω) 
and increased permeability due to loss of barrier phenotype in cultured cells (55, 56). When subsequent 
evidence suggested that glial cells dynamically interact with and regulate barrier properties the 
development of various approaches to mimic the glial influence was stimulated. Dehouck and 
colleagues (59) proposed an enhanced 2D model by co-culturing astrocytes on the opposite face of the 
porous membrane (contact model) allowing closer recreation of the interactions that occur in vivo (see 
Fig. 1). Others cultured astrocytes on the bottom of the well in which the membrane is inserted (25) the 
so-called non-contact model, or used astrocyte-conditioned media harvested from growing astrocyte 
cultures (56, 61). Such practices are now commonplace in the field but despite the fact that co-culturing 
induces higher TEER values than monocultures the degree of induction remains significantly lower 
than the in vivo situation (62).  
More recently it was shown that pericytes also increase the integrity of endothelial monolayers (32, 63, 
64) and the presence of both astrocytes and pericytes produces optimal induction of the barrier 
phenotype (50, 65). Indeed such triple cultures are a step closer to the interactions that occur in vivo 
and are currently gaining popularity in the field. Further enhancement of barrier function can be 
achieved by applying flow-induced shear stress across the monolayer (23, 66, 67). To achieve this a 
parallel plate flow chamber is frequently used such as employed in studies investigating sequential 
leukocyte interactions with human microvascular endothelial cells under flow conditions (68, 69). 
Siddharthan et al also developed a dynamic flow system consisting of a transparent plastic chamber 
that housed a snapwell insert cultured with human microvascular endothelial cells that could be 
subjected to peristaltic flow (70).  
All of these 2D models have facilitated studies of the contribution of cell-cell interactions and external 
influences (such as pharmacological compounds and inflammatory cells) to barrier function at a 
cellular and mechanistic level without interference from other physiological responses. In addition to 
being able to directly assess barrier function, these models facilitate the investigation of altered 
signaling pathways and mechanisms within the individual cell compartments. This has been exploited 
by some researchers to investigate the contribution of astrocytes (50), pericytes (50, 65, 71), neurons 
(72, 73), neural precursor cells (74, 75) as well immune cells (76) to barrier integrity. Notably these 
models offer the possibility of reasonably high throughput results and relatively good reproducibility.  
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However despite providing important information 2D models represent an oversimplified view of the 
BBB. These models do not take into account the 3-dimensional structure of blood vessels, the complex 
cellular interactions of cells that comprise the BBB, alteration of cellular properties as a result of lack 
of one or more cellular constituents or exposure to shear stress. It seems likely that this has only 
contributed to the discordance between in vitro and in vivo results. Thus in both the basic research and 
pharmaceutical worlds the search continues for appropriate 2D models that are more representative of 
the in vivo situation and more reliable for drug screening. Recent reports of mouse, rat and human cell-
based BBB models that have high drug permeability correlation coefficients with in vivo data, and are 
possibly suitable for discriminating CNS and non-CNS compounds, may bring that objective one step 
closer (77-79) 
 
3D models 
More recently, growing realization that cells behave differently in 2D versus 3D environments have led 
some researchers to be convinced that more relevant information can be gained from the study of BBB 
cells in 3D environments. This notion is underlined by the fact that cells of the BBB have a very 
specific spatial orientation that probably makes a large contribution to the way in which they 
communicate with each other and maintain barrier cross-talk. This consideration is an important yet 
regularly overlooked aspect that may contribute to our limited knowledge of barrier properties. Thus 
new models that offer the advantage of a relatively simplified in vitro system but are more 
representative of (complex) native BBB structure, allowing dynamic movement and reorganization of 
cells as well as remodeling of the surrounding matrix molecules in response to a changing 
environment, are sorely needed.  
In an effort to better address cellular organization and interactions at the BBB and define the molecular 
mechanisms underlying these events, a few 3D in vitro cell systems have been established.  
 
3D collagen matrix models 
Endothelial cells undergo morphological changes when grown within a type I collagen matrix that 
include organization into tube-like structures (80-83) and are accompanied by changes in growth factor 
receptor profiles and extracellular matrix protein production (84, 85). Some 3D systems involving 
microvascular endothelial co-culture with astrocytes and neurospheres have also been published (49, 
86).  
This methodology has been recently adapted to develop and characterize an innovative 3D BBB model 
(87) that includes all 3 barrier cells and allows them to display their unique morphology as occurs in 
vivo (86, 88). In this model astrocytes, endothelial cells and pericytes are seeded together within the 
matrix in singe cell suspension. Although endothelial cells cultured alone could form patent vascular 
structures, improper ABC transporter and junctional protein localization within the tubes highlighted an 
important limitation of the monocultures (87). It was demonstrated that astrocyte and/or pericyte 
interactions with the endothelial tubes were required to induce adequate junctional complex 
localization and endothelial tube polarization in 3D, an observation correlating well with establishment 
of improved barrier phenotype in 2D co-culture models (50, 65). Astrocyte and pericyte contact with 
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the vascular structures improved barrier protein localization and effectively induced luminal efflux and 
accumulation of a P-glycoprotein substrate (87) demonstrating both the presence and activation of an 
efficient transport mechanism and vascular integrity (89-91). Astrocytes and pericytes also modulated 
endothelial proliferation and tube morphogenesis. This 3D model is also very dynamic. Hypoxia, a 
characteristic state of various pathologies that disrupt the BBB (92, 93), modulates both protein 
localization and cellular interactions within the model system. For example acute hypoxia increased 
astrocyte coverage of tube structures whereas prolonged hypoxia triggered loss of contacts and vascular 
swelling (87) as occurs during injury in vivo (41). Thus this 3D model displays responses known to 
occur in vivo confirming it is highly representative of the in vivo situation. In addition this study 
supported the concept that co-culturing the 3 cell types is important for cell structure, organization and 
barrier modulation.  
However as with all in vitro models there are caveats. Until now, it remains difficult to assess the 
tightness of the in vitro tubes formed. Specific and appropriate cell-cell interaction, TJ expression and 
transporter activity suggest significant barrier function but it remains very hard to assess directly. There 
is also the issue of absence of flow that could be an important contributor for the modulation of cell-
cell interactions. Nevertheless models such as this offer a new approach to investigate dynamic 
interactions and the specific contribution of barrier (and non-barrier) cells to complex mechanisms at 
the BBB during physiological and pathological conditions.  
 
3D flow systems 
The continuous exposure of endothelial cells to shear stress, generated by blood flow across their apical 
surfaces, may have important effects on endothelial differentiation and metabolism. Although most in 
vitro BBB models lack the presence of shear stress, some investigators have more fully imitated the 
physiological environment by exposing microvascular endothelial cells grown in three dimensions to 
flow (94, 95). Ott et al. developed a hollow fiber cell culture apparatus for this purpose wherein 
endothelial cells were seeded intraluminally within the capillary-like structure and exposed to 
continuous peristaltic flow (95). Only a few groups have reported further studies using this model. 
Janigro and coworkers are continuously developing the system and have gone one step further by 
seeding the endothelial cells intraluminally while culturing glia on the extraluminal surface of the 
hollow fiber tube (96, 97). This induced a BBB-specific phenotype with low permeability to 
intraluminal potassium, negligible extravasation of proteins, and the expression of a glucose 
transporter. In addition, co-culturing affected the overall morphology of the cells and induced the 
expression of BBB-specific ion channels (96). The model also supports continuous real-time 
monitoring of BBB function by measurement of TEER across the barrier via electrodes inserted in the 
luminal and abluminal compartments and was reported to generate a restrictive paracellular pathway of 
more than 700Ω (96). Furthermore exposure to controlled pumping rates makes the model suited for 
the study of endothelial cell responses to a wide range of shear stress. Neuhaus et al. (98) also 
established a flow based hollow-fiber in vitro model of immortalized porcine brain microvascular 
endothelial cells co-cultured with glia cells. Again monolayer tightness of the model was significantly 
enhanced by co-culture and surprisingly the system could be maintained for up to 4 months. Cell 
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attachment and morphology was monitored by environment scanning electron microscopy and showed 
that the endothelial cells formed a monolayer intraluminally with an elongated morphology presumably 
due to the influence of pulsatile flow whereas the glial cells grew as a multilayer with their end feet 
contacting the monolayer. An exciting step for development of these models will be the addition of 
pericytes to the system.  
Dynamic flow systems foster morphological development that better resemble the endothelial 
phenotype in situ, more differentiated endothelial cells compared to conventional culture, significantly 
increased TEER and decreased permeability as well as a remarkably longer lifetime (96-100). 
However, although they represent highly innovative approaches, the high cost and technical demands 
of these models means they have not been adopted in many research labs or used as possible BBB 
permeability screens. Furthermore, despite high TEER and low permeability values there is still the 
question of how well the cellular organization within the hollow fibers really correlates to the in vivo 
situation, especially as the cells can be difficult to image. Hopefully in time these systems will become 
more accessible to the wider community.   
 
In vitro versus in vivo models. 
While it is clear that in vitro models represent highly simplified systems of the BBB, their usefulness 
and power should not be under estimated. In a climate where the use of animals and translation of data 
from such experiments is highly scrutinized in vitro models frequently offer an easy, cost-effective 
alternative. In vitro models also represent a way to study cell-specific contributions, mechanisms and 
signaling processes in a way that is not possible, or at least very challenging, in vivo. However, it is 
becoming ever more evident that the complexity of currently utilized in vitro models needs to be 
addressed to bring them closer to in vivo relevance - single and 2 cell systems seem to no longer fulfill 
this requirement. Thus there is a great need for development of better, more representative in vitro 
model systems such as those reviewed in this article. Nevertheless as both in vitro and in vivo models 
have pros and cons it ultimately seems that the combination of both systems will provide the optimal 
route to unlock the secrets of induction, maintenance and disruption of BBB function.  
 
Conclusions 
Mechanisms of BBB induction, maintenance and dysfunction are for the large part still a black box. To 
enable the development of new drugs and therapeutics to combat BBB compromise and brain disease 
we need to gain more knowledge of how the complex cellular interactions at the BBB modulate 
different aspects of barrier signaling. It is apparent that in vitro models have a significant role to play 
but new multi-cellular models that are simplified, but still complex, must be developed to bring them 
closer to in vivo relevance. More versatile in vitro models, in combination with in vivo models, will 
undoubtedly be the key to understanding the cellular and molecular mechanisms underlying BBB 
regulation during physiological and pathological situations. Selectively modulating barrier function 
will remain a significant challenge for all scientists in the BBB field for a while to come. 
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